Advertisement

Topics

Latest Infectious-diseases NewsRSS

13:01 EST 15th December 2018 | BioPortfolio

Magnetic Resonance Elastography to Predict Hepatocellular Carcinoma After Eradication of Chronic HCV Infection

Liver-stiffness values can predict risks for hepatocellular carcinoma in chronic hepatitis C.

Enzalutamide/Radium-223 Combo Shows Potential in mCRPC

Benjamin L. Maughan, MD, PharmD, discusses the activity of the combination of radium-223 and enzalutamide in patients with metastatic castration-resistant prostate cancer.

Walgreens Launches Flu Index™ for 2018-2019 Season

The fifth seasonal Flu Index kicks off with Brownsville, Texas topping the list for flu activity; it serves as an important reminder to take preventive measures to stay healthy this flu season With holiday travel around the corner and flu activity on the rise in many parts of the country, Walgreens today launched its first Flu Index™ for the 2018-201...

Antibiotic with novel mode of action effective against gonorrhoea infection

A novel antibiotic, which prevents bacterial cells from replicating DNA, is effective in the treatment of uncomplicated urogenital gonorrhoea, results from a phase II clinical trial have shown.

A survey on incidence and management of adenovirus infection after allogeneic HSCT

MicroRNAs derived from the insect virus HzNV-1 promote lytic infection by suppressing histone methylation

Mymetics Corp MYMX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryMymetics Corp Mymetics is a biotechnology company that develops nextgeneration prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus HSV and respiratory syncytial virus RSV. Mymetics uses its proprietary technology which deploys virosomes and lipidbased...

CORRECTING and REPLACING Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Second paragraph, first sentence of release dated December 12, 2018, should read: ... Food and Drug Administration (instead of...Federal Drug Administration). The corrected release reads: ADAPTIVE PHAGE THERAPEUTICS ENTERS INTO COLLABORATION AGREEMENT WITH RESEARCHERS AT YALE UNIVERSITY TO MANUFACTURE AND SUPPLY THERAPEUTIC BACTERI...

Newly Published Case Series Demonstrates the Karius Test’s Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections

Karius and Clinical Investigators from UCSF Showed that the Karius Test can Quickly and Accurately Detect Infections Earlier than Standard Diagnostics in Immunocompromised Patients REDWOOD CITY, Calif. (PRWEB) December 13, 2018 Karius, Inc., a life sciences company transforming infectious disease diagnostics with genomics, announced today the results of an ongoing clinical study of adult patients...

The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model

Treating M. abscessus infection is challenging due to the potent β-lactamase BlaMab (Beta-lactamase of M. abscessus). Avibactam is a non-β-lactam, β-lactamase inhibitor shown to inhibit BlaMab. We tested whether ...

Your NEJM Group Today: 1918 Flu Pandemic / Opioids After Gynecologic Surgery / Wash. State ID Opportunity

Check out today's highlights from NEJM Group: NEJM Audio Interview: The Influenza Pandemic, a Century Later: Dr. David Morens discusses lessons from the 1918 influenza...

Haidian District People’s Court in Beijing Issues Injunction Order Restraining Aihua Pan from Using Business License and Corporate Seal of Sinovac Beijing

Interim Injunction Order Restrains Mr. Aihua Pan from using business license and corporate seal of Sinovac Beijing obtained with documents containing forged signature of Mr. Weidong Yin and forged corporate seal of Sinovac HK Sinovac Biotech Ltd. (“Sinovac” or the “Company”) announced that the People’s Court in Haidian District, Beijing (the ...

Vibrio coralliilyticus infection triggers a behavioural response and perturbs nutritional exchange and tissue integrity in a symbiotic coral

Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced it has entered into a collaboration agreement with the Paul Turner Lab at Yale University to manufacture and supply therapeutic bacteriophage (ph...

Which Skin Infection Patients Need Hospitalization?

Without a control group, this retrospective case series does not alter current thinking.

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

FLORENCE, Italy, December 12, 2018 /PRNewswire/ -- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections  The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in Europe  The Menarini Group has recently reached an agreement wi...

At a young age, Dr. Gokul Swaminathan of @Merck became fascinated by pathogens and infectious diseases. Today, he’s working alongside other researchers to develop individualized ways to treat these diseases. Learn more: http://bit.ly/2Uv8gcK  #GoBoldl

At a young age, Dr. Gokul Swaminathan of @Merck became fascinated by pathogens and infectious diseases. Today, he’s working alongside other researchers to develop individualized ways to treat these diseases. Learn more: http://bit.ly/2Uv8gcK  #GoBoldly pic.twitter.com/MnaaPqqrwf

SEIU 775 Benefits Group Partners with SR Max Slip Resistant Shoes to Launch Caregiver Kicks

25,000 slip resistant shoes to be distributed to caregivers throughout Washington State SEIU 775 Benefits Group, the nation’s leading organization dedicated to improving the skills, health, and sustainability of the home care workforce, is partnering with SR Max Slip Resistant Shoes in order to offer slip resistant footwear to caregivers at no cost t...

Worcester Polytechnic Institute Researchers Developing a Biosensor That Can Speed Diagnosis of Potentially Deadly Bacterial Infection

The sensor, which detects the presence of C. diff bacteria, could be used in doctor’s offices and nursing homes, speeding treatment and decreasing the severity of the disease WORCESTER, Mass. (PRWEB) December 11, 2018 Researchers at Worcester Polytechnic Institute (WPI) are developing a biosensor that doctors and nurses can use to quickly detect Clostridium difficile (C. diff), a dangerous and ...

Antimicrobial Chemical Tied to Antibiotic Resistance Genes in Dust

NewsAn antimicrobial chemical found to be abundant in dust may result in dust with organisms that could cause antibiotic-resistant infection.

Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer

Aravive (Nasdaq:ARAV), a clinical-stage biopharmaceutical company, today announced that the company has begun treating patients in the Phase 1b portion of a Phase 1b/Phase 2 trial combining AVB-S6-500 with standard-of-care therapies in patients with platinum-resistant recurrent ovarian cancer. As quoted in the press release: “We are excited to have begun enrollment in this clinical trial …...

Key Cellular Mechanism That Triggers Pneumonia Discovered

NewsResearchers have demonstrated that influenza virus impairs the immune response to pneumococcus, especially monocyte activity.

Global Travel Vaccines Market 2018-2022 | Increase in Global Travel and Migration to Boost Growth | Technavio

Technavio analysts forecast the global travel vaccines market to grow at a CAGR of close to 10% during the forecast period, according to their latest market research report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005669/en/

Immunotherapy Offers Hope to Neurofibromatosis Type 1 Brain Tumor Patients

Although brain tumors have largely remained resistant to immunotherapy, a new study has shown that a slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to that treatment approach. The findings (“The molecular landscape of glioma in patients with Neurofibromatosis 1”), made by an international consortium led by researchers […] The pos...

BioDiem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryBioDiem Ltd BioDiem is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company's product portfolio includes Live Attenuated Influenza Virus LAIV vaccine technology,...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Infectious-diseases market research data and corporate reports here